Biomarkers – evolving role of neurofilament light
Oral cladribine – two reports
Vitamin D improves corticosteroid efficacy
First visit influences patient satisfaction, treatment start Read More

Thursday, October 11, 2018 – Poster Session 2 – 5:15 – 7:15 PM
Here are Steven’s Top 10 poster topics at ECTRIMS for Thursday, October 11, 2018. Read More

Wednesday, October 10, 2018 – Poster Session 1 – 5:00 – 7:00 PM
Here are Steven’s Top 10 poster topics at ECTRIMS for Wednesday, October 10, 2018. Read More

Teva Pharmaceuticals has announced that it will no longer pursue the commercial development of laquinimod, a small-molecule aryl hydrocarbon receptor activator, in neurodegenerative diseases. The development and commercialization rights will revert back to Active Biotech, the company that originated the molecule. Read More

The University of Buffalo MS group has reported that comorbid cardiovascular disease appears to contribute to more rapid brain tissue loss in patients with multiple sclerosis (Jakimovski et al. Eur J Neurol 2018; epublished August 13, 2018). Read More